Hiroshima, Japan

Nobuhiko Miwa

This inventor holds 2 USPTO granted patents. Top assignees: Dai-Ichi Kogyo Seiyaku Co., Ltd., Other. Active years: 1992-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuhiko Miwa. Retrieved from https://idiyas.com/inventor/nobuhiko-miwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal2 out of 252 
 
Dai-Ichi Kogyo Seiyaku Co., Ltd.
 patents
silverMedal2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobuhiko Miwa: Innovator in Pharmaceutical Compositions

Introduction

Nobuhiko Miwa is a notable inventor based in Hiroshima-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of carcinostatic compositions. His work focuses on innovative methods for cancer treatment that aim to minimize side effects.

Latest Patents

Nobuhiko Miwa holds 2 patents. His latest patents include "Carcinostatic compositions and methods," which present pharmaceutical compositions comprising a diol represented by specific formulas. These compositions are designed for the treatment of cancer in animals, providing effective solutions without causing adverse side effects. Another patent involves pharmaceutical compositions and methods for treatment and prophylaxis, which utilize an isomonool that exhibits carcinostatic and carcinogenesis-preventing activity.

Career Highlights

Throughout his career, Nobuhiko Miwa has worked with prominent companies, including Dai-Ichi Kogyo Seiyaku Co., Ltd. His innovative approaches have contributed to advancements in cancer treatment methodologies.

Collaborations

Nobuhiko Miwa has collaborated with notable coworkers such as Shingo Nakamura and Yoshichika Nishimura. Their combined efforts have furthered research and development in the pharmaceutical sector.

Conclusion

Nobuhiko Miwa's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the field. His work continues to impact the development of effective and safe therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…